Linnaeus Therapeutics, Inc.

New Filing

CIK: 0001752026·Biotechnology·DELAWARE·Filed: Aug 24, 2021

Total Offering

$4,344,675

Amount Sold

$4,344,675

Investors

15

First Sale

Aug 9, 2021

Offering Details

Type: Equity
Exemptions: Rule 506(b), Section 4(a)(5)
Entity Type: Corporation
Non-Accredited Investors: No

Related Persons

Name	Role
Patrick T. Mooney	Related Person
Todd T. Thomson	Related Person
Nicholas T. Iatropoulos	Related Person
Michael D. Poisel	Related Person

Company

Linnaeus Therapeutics, Inc.

30 WASHINGTON AVENUE, SUITE F

HADDONFIELD, NJ, 08033

8564331500

SEC Filing

0001752026-21-000003

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.